期刊文献+

人重组型caspase-6融合蛋白对骨肉瘤E10细胞的靶向促凋亡作用

The targeted pro-apoptotic effect of human recombinant caspase-6 fusion protein on osteosarcoma E10 cells
下载PDF
导出
摘要 目的:探讨Her2靶向重组人caspase-6融合蛋白对骨肉瘤E10细胞的促凋亡作用。方法:将抗Her2单链抗体基因e23sFv与绿脓杆菌外毒素PE的转膜结构域基因(PEⅡ)和重构型caspase-6基因连接,构建成immunocaspase-6(e23sFv-PEⅡ-caspase-6)基因,将其克隆入质粒pCMV中,阳离子脂质体包裹法转染E10细胞;HE染色、电子显微镜观测转染后细胞形态学变化;免疫细胞化学染色检测目的基因表达;MTT法检测目的基因转染后细胞的生长状况。结果:目的基因转染后,HE染色、电子显微镜观察到细胞呈现典型的凋亡特征,免疫细胞化学染色检测出caspase-6的表达,MTT法检测发现细胞的增殖被明显抑制(P≤0.01)。结论:Her2靶向重组的人caspase-6融合蛋白能识别、结合Her2+骨肉瘤E10细胞,并促使其凋亡。 Objective To investigate the pro-apoptotic effect of Her2 targeted recombinant caspase-6 fusion protein on osteosarcoma E10 cells. Methods Recombinant immunocaspase-6 was generated by sequential fusion of the genes of a signal peptide, a single-chain Her2 antibody (e23sFv), a PEA translocation domain (PEA aa253-364), and an recombinant caspase-6. The pCMV-immunocaspase-6 was produced by cloning immunocaspase-6 gene into pCMV plasmid, and then the pCMV-immunocaspase-6 mixed cationic liposome was transfected into E10 cells. The effects of target gene expression on morphology and growth status of E10 cells were observed by HE staining and electron microscopy and analyzed by immunocytochemical staining and MTr assay. Results The fusion protein was detected in the cytoplasm of the transfected E10 cells. These cells presented the typical characteristics of apoptosis as detected by HE staining and electron microscopy. MTT assay revealed that the proliferation of immunocaspase-6 gene-transfected E10 cells was much lower than that of non- or mock-transfected cells (P≤0.01). Conclusion Her2 targeted human recombinant caspase-6 fusion protein can induce apoptosis of Her2-overexpressing E10 cells.
出处 《实用医学杂志》 CAS 2007年第8期1107-1109,共3页 The Journal of Practical Medicine
基金 国家自然科学基金重点项目(编号:30330610) 国家自然科学基金面上项目(编号:30471988)
关键词 骨肉瘤 丰胱氨酸天冬氨酸蛋白酶 细胞凋亡 Her2 融合蛋白 Osteosarcoma Caspases Apoptosis Her2 Fusion protein
  • 相关文献

参考文献10

  • 1YIN Xiao-ming.Bid,a BH3-only multi-functional molecule,is at the cross road of life and death[J].Gene,2006,369:7-19.
  • 2Madesh M,Antonsson B,Srinivasula S M,et al.Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization[J].J Biol Chem,2002,277(7):5651-5659.
  • 3裘秀春,单乐群,许彦鸣,杨彤涛,张殿忠,文艳华,刘云燕,杨连甲,杨安钢,范清宇.骨肉瘤HER2基因表达增加肺转移发生危险度[J].实用医学杂志,2006,22(2):123-124. 被引量:5
  • 4Batra J K,Kasprzyk P G,Bird R E,et al.Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin[J].Proc Natl Acad Sci USA,1992,89(13):5867-5871.
  • 5Srinivasula S M,Ahmad M,Macfarlane M,et al.Generation of constitutively active recombinant caspase-3 and -6 by rearrangement of their subunits[J].J Biol Chem,1998,273(17):10107-10111.
  • 6Xu Y M,Wang L F,Jia L T,et al.A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors[J].J Immunol,2004,173(1):61-67.
  • 7陈翔,杨彤涛,马保安,范清宇.不同转移潜能骨肉瘤细胞株的建立与生物学性质的分析[J].第四军医大学学报,2005,26(21):1992-1995. 被引量:2
  • 8Philchenkov A A.Caspases as regulators of apoptosis and other cell functions[J].Biochemistry (Mosc),2003,68(4):365-376.
  • 9Kukhta V K,Marozkina N V,Sokolchik I G,et al.Molecular mechanisms of apoptosis[J].Vkr Biokhim Zh,2003.75(6):5-9.
  • 10Yu C J,Jia L T,Meng Y L,et al.Selective proapoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2[J].Gene therapy,2005,13 (4):313-320.

二级参考文献17

  • 1朱伟勇,郑杰,方伟岗,王洁良,由江峰,崔湘琳,吴秉铨.具有不同转移潜能的肺癌细胞亚系的分离鉴定[J].中华病理学杂志,1995,24(3):136-138. 被引量:22
  • 2Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis[J]. Cancer Res,1978;38(9):2651-2660.
  • 3Hart IR. The selectiom and characterization of an invasive variant cells of the B16 melanoma[J]. Am J Pathol,1979;97(3):587-600.
  • 4鄂征.组织培养技术(第2版)[M].北京:人民卫生出版社,1998.153-156.
  • 5MEYERS P A, GORLICK R. Osteosarcoma [J] . Pediatr Clin North Am, 1997,44 (4): 973 - 989.
  • 6TOIKKANEN S, HELIN H, ISOLA J, et al. Prognostic significance of IIER-2 oncoprotein express on n breast cancer: a 30-year follow-up [J ].J Clin Oncol, 1992,10(7): 1044 - 1048.
  • 7BAXEVANIS C N, SOTIROPOULOU P A, SOTIRIADOU N N,et al. Immunobiology of HER2/ncu oncoprotein and its potential application in cancer immunotherapy. Cancer Immunol Immunother[J].2004,53(3): 166-175.
  • 8HIRSCH F R, LANGER C J. The role of HER2/neu expression and trastuzumab in non-small cell lung cancer [J]. Semin Oncol,2004,31(1 suppl 1):75-82.
  • 9ZHOU H, RANDALL R L, BROTHMAN A R, et al. HER2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification [J]. J Pediatr Hematol Oneol, 2003,25(1): 27-32.
  • 10MORRIS C D, GORLICK R, HHVOS G, et al. Human epidermal growth factor receptor 2 as a prognostic indicator in Osteogenic Sarcoma [J].Clin Orthop Relat Res, 2001, (382): 59- 65.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部